Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGRX | SLGL | MGX | ||
| Company | Agile Therapeutics Inc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 1.5100 | 74.80 | 1.4700 | ||
| High | 1.5150 | 83.25 | 1.4700 | ||
| Low | 1.5100 | 74.80 | 1.4200 | ||
| Latest | 1.5100 | 76.01 | 1.4400 | ||
| Change | unch | +3.71 | +0.0100 | ||
| % Change | unch | +5.13% | +0.70% | ||
| Volume | 120,900 | 31,332 | 35,076 | ||
| 20-Day Average Volume | 65,545 | 63,085 | 197,535 | ||
| Previous Close | 1.5100 | 72.30 | 1.4300 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4681 | 75.28 | 1.4038 | ||
| 20-Day Raw Stochastic | 87.50% | 60.36% | 66.67% | ||
| 20-Day Relative Strength | 81.96 | 51.21 | 49.44 | ||
| Weighted Alpha | -73.36 | +412.49 | -27.76 | ||
| Today's Opinion | 88% Buy | 56% Buy | 80% Sell | ||
| Previous Opinion | 88% Buy | 40% Buy | 80% Sell | ||
| Last Month's Opinion | 56% Buy | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 08/19/24 | +4.64% since 04/17/26 | -2.03% since 04/17/26 | ||
| Low | 1.4400 on 08/22/24 | 69.61 on 04/20/26 | 1.4000 on 04/23/26 | ||
| High | 1.5200 on 08/22/24 | 83.25 on 04/24/26 | 1.5500 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +4.14% since 07/26/24 | -3.39% since 03/24/26 | +5.84% since 03/24/26 | ||
| Low | 1.4300 on 07/29/24 | 65.07 on 03/30/26 | 1.2500 on 03/30/26 | ||
| High | 1.5200 on 08/22/24 | 85.32 on 04/01/26 | 1.5500 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +302.77% since 05/24/24 | +32.26% since 01/23/26 | -14.20% since 01/23/26 | ||
| Low | 0.3100 on 06/20/24 | 55.51 on 01/26/26 | 1.2500 on 03/30/26 | ||
| High | 1.5200 on 08/22/24 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +86.83% since 02/26/24 | +98.19% since 10/24/25 | -49.83% since 10/24/25 | ||
| Low | 0.2000 on 03/26/24 | 28.81 on 11/13/25 | 1.2500 on 03/30/26 | ||
| High | 1.5200 on 08/22/24 | 97.97 on 03/03/26 | 2.9399 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,353 | 203,156 | 53,798 | ||
| Shares Outstanding, K | 6,856 | 2,810 | 37,621 | ||
| Annual Sales | 19,590,000 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -14,470,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 5,580,000 | 700,000 | 3,910,000 | ||
| Last Quarter Net Income | -11,870,000 | -2,990,000 | -22,530,000 | ||
| 60-Month Beta | 1.58 | 1.26 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 08/12/24 | -1.07 on 03/19/26 | -0.60 on 03/05/26 | ||
| Latest Earnings Date | 11/14/24 | 05/22/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||